Journal of Nephropharmacology (Jan 2023)

COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report

  • Ali Hajigholami,
  • Hourieh Ansari,
  • Sakineh Ansari,
  • Shakiba Hassanzadeh

DOI
https://doi.org/10.34172/npj.2022.10454
Journal volume & issue
Vol. 12, no. 1
pp. e10454 – e10454

Abstract

Read online

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease (COVID-19) pandemic is the largest infectious crisis in the present century. It has been reported that COVID-19 infection may trigger autoimmune diseases. Herein, we report a 68-year-old male that was diagnosed with thrombotic thrombocytopenic purpura (TTP) following COVID-19 infection. To our knowledge, this is the fourth case of COVID-19-associated TTP. More attention is required regarding the possibility of developing TTP in COVID-19 patients, especially with the presence of decreased consciousness and low levels of hemoglobin and platelet.

Keywords